Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 24.16% | 20.21% | 6.35% | 9.27% | 7.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.16% | 20.21% | 6.35% | 9.27% | 7.07% |
| Cost of Revenue | 3.30% | 0.01% | -5.31% | -2.72% | 5.80% |
| Gross Profit | 28.10% | 24.03% | 8.45% | 11.42% | 7.31% |
| SG&A Expenses | 21.58% | 17.72% | 21.09% | 24.41% | 35.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 38.31% | 40.28% | 31.19% | 29.28% | -26.96% |
| Total Operating Expenses | 18.58% | 14.81% | 14.14% | 17.27% | 21.27% |
| Operating Income | 12.62% | 15.40% | -152.27% | -159.20% | -370.59% |
| Income Before Tax | 52.38% | 53.90% | -100.12% | -105.61% | -459.95% |
| Income Tax Expenses | 178.45% | 169.95% | 165.71% | 167.29% | 37.74% |
| Earnings from Continuing Operations | 47.21% | 48.89% | -112.05% | -117.86% | -491.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 47.21% | 48.89% | -112.05% | -117.86% | -491.60% |
| EBIT | 12.62% | 15.40% | -152.27% | -159.20% | -370.59% |
| EBITDA | 18.74% | 21.32% | -808.71% | -833.55% | -1,594.00% |
| EPS Basic | 48.21% | 49.12% | -111.11% | -123.53% | -500.00% |
| Normalized Basic EPS | 52.94% | 54.29% | -100.00% | -109.09% | -477.78% |
| EPS Diluted | 48.21% | 49.12% | -111.11% | -123.53% | -566.67% |
| Normalized Diluted EPS | 52.94% | 54.29% | -100.00% | -109.09% | -477.78% |
| Average Basic Shares Outstanding | 0.37% | 0.37% | 0.33% | 0.33% | 0.20% |
| Average Diluted Shares Outstanding | 0.37% | 0.37% | 0.33% | 0.33% | -4.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
